menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo Nordisk slides on pressure from Lilly’s pill study

8 13
22.04.2025
The Eli Lilly & Co. study puts pressure on Novo, whose market value has dropped by a third since the start of the year.

© Fortune